BioSig in the News :: BioSig Technologies, Inc. (BSGM)

The Power and Precision of BioSig's PURE EP™ System in the Electrophysiology (EP) Market

At the Crossroad of Healthcare and Technology: Unlocking the Potential of Biomedical Signals

Exclusive Interaction with Natasha Drapeau, Executive Vice President, BioSig

Q&A: Developing sensing technologies for physiological and neurological disorders

BioSig Employs Vuzix Smart Glasses in Pure EP Rollout

The Future of Medicine is Here: Bioelectronic Medicine

BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System

Westport Company May Hold Key To COVID Anti-Viral Drug

Near ‘Party Zero’ in Westport, firm tackles possible coronavirus cure

View All Media Coverage News

Video Resources

BioSig Technologies Completes Enrollment in its PURE EP 2.0 Clinical Trial

BioSig Technologies forms three new evaluation agreements for its PURE EP System

BioSig forms R&D program with Mayo Clinic to develop AI and machine learning for its PURE EP System

SumZero Headlines: Ken Londoner on Biotech Solutions in Signal Processing

The Future of Bioelectronic Medicine with Suraj Kapa, M.D.

Nasdaq Spotlight: Interview with Ken Londoner

Ken Londoner interviewed by Christine Corrado for Proactive Investors

Ken Londoner interviewed by Ray Hoffman for CEO Radio-WCBS

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market

View All Video Resources News